Pfizer Talzenna/Xtandi combo approved for earlier prostate cancer setting

FDA approves Pfizer's Talzenna plus Xtandi for earlier metastatic prostate cancer. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real